Page 100 - Amgen News Today

Here are the most important news items that investors need to start their trading day.

Doping tests are done to prevent unethical ways to win games since early 90s. Since then, many famous athletes were caught using steroids to win a sport and set a mark in history.

Plus, China wants Microsoft and Intel off its computer

Amgen (NASDAQ:AMGN) shares began a shortened week ahead of the weekend, on word the company is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. The biotech company ...

Amgen sued Colorado's Prescription Drug Affordability Board over its decision to consider setting a price cap on arthritis drug Enbrel

Assenagon Asset Management S.A. grew its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 486.6% in the fourth quarter, Holdings Channel reports. The firm owned 899,232 shares of the medical research company’s stock after acquiring an additional 745,929 shares during the period. Amgen accounts for approximately 0.7% of Assenagon Asset Management S.A.’s […]

Assenagon Asset Management S.A. lifted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 486.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 899,232 shares of the medical research company’s stock after buying an additional 745,929 shares during the quarter. Amgen […]

Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.

Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.

In an exciting collaboration, NVIDIA, a leading chipmaker, and healthcare startup Hippocratic AI have joined hands to embark on a groundbreaking project aimed at transforming the landscape of healthcare.